USANA CEO awarded 82,726 restricted stock units
USANA Health Sciences CEO Kevin Guest reported an equity award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
USANA Health Sciences CEO Kevin Guest reported an equity award. On February 19, 2026, he acquired 82,726 restricted stock units at a stated price of $0.00 per unit. Each unit is a contingent right to receive one share of USANA common stock.
The restricted stock units vest 25% on each 19th of February thereafter under the grant terms. Following this award, Guest directly held a total of 135,062 restricted stock units in USANA.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 82,726 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
- F2. On February 19th 2026, the reporting person was granted restricted stock units, vesting at 25% on each 19th of February thereafter.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did USANA (USNA) report for Kevin Guest?
How many USANA (USNA) restricted stock units does Kevin Guest hold after this grant?
What are the vesting terms of Kevin Guest’s new USANA (USNA) restricted stock units?
What does each USANA (USNA) restricted stock unit granted to Kevin Guest represent?
Was there a purchase price for Kevin Guest’s USANA (USNA) restricted stock unit award?
AI-generated analysis. How Rhea-AI works. Not financial advice.